Tregs suppress antitumor immunity by inducing apoptosis in CD8+ T cells, producing IL-10 to inhibit NK cells and conversion of TH17 and TH1 cells, thus creating an immunosuppressive TME that supports CRC progression (71, 72). This evidence concerns the gene CD8A and colorectal carcinoma.